SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Avanir Pharmaceuticals (AVN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Tadsamillionaire8/24/2005 3:38:26 PM
  Read Replies (1) of 166
 
Allergan CFO Eric Brandt resigns to become Avanir Pharma CEO
Tuesday August 23, 5:05 pm ET
By Carla Mozee

SAN FRANCISCO (MarketWatch) -- Allergan Inc. said after Tuesday's closing bell that Chief Financial Officer Eric Brandt has resigned, effective Sept. 5, to become chief executive of Avanir Pharmaceuticals . Irvine, Calif.-based Allergan named Jeffrey Edwards CFO, succeeding Brandt. Edwards has served as Allergan's corporate vice president of corporate development since 2002 and has worked at Allergan since 1993.

biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext